1998
DOI: 10.1016/s0003-4975(98)00357-9
|View full text |Cite
|
Sign up to set email alerts
|

Preconditioning with cromakalim improves long-term myocardial preservation for heart transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0
1

Year Published

1999
1999
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 27 publications
1
5
0
1
Order By: Relevance
“…Glibenclamide administered alone did not prolong cardiac allograft survival, whereas combined with aprikalim it prolonged cardiac allograft survival. This result is similar to Kirsch's report 16 that preconditioning with cromakalim (a K + channel opener) modestly improved long-term myocardial preservation for heart transplantation, whereas glibenclamide did not abolish the effects of cromakalim. The K + ATP channel inhibitor, gliclazide, prolonged cardiac allograft survival compared to control group, but the mechanism remains unknown.…”
Section: Discussionsupporting
confidence: 90%
“…Glibenclamide administered alone did not prolong cardiac allograft survival, whereas combined with aprikalim it prolonged cardiac allograft survival. This result is similar to Kirsch's report 16 that preconditioning with cromakalim (a K + channel opener) modestly improved long-term myocardial preservation for heart transplantation, whereas glibenclamide did not abolish the effects of cromakalim. The K + ATP channel inhibitor, gliclazide, prolonged cardiac allograft survival compared to control group, but the mechanism remains unknown.…”
Section: Discussionsupporting
confidence: 90%
“…High-risk patients with poor preoperative left ventricular function, extensive coronary artery disease, or severe left ventricular hypertrophy could certainly benefit if the degree of protection were improved by invoking endogenous cellular adaptive mechanisms. The possibility that organ preservation before transplantation might be amenable to the same improved protection, as suggested by some experimental evidence, 81,82 is also of significant interest. This might allow an extension of the "cold ischemic time" between harvesting and implantation, facilitating optimal matching of recipient to donor, as well as affording a potential improvement in early myocardial function.…”
Section: Which Patients May Benefit?mentioning
confidence: 99%
“…So far HSP72 has been implicated with protection of graft survival in several studies [13, 24, 25, 26, 27, 28]. For instance, Amrani et al [28]showed that hearts from animals subjected to heat shock before hypothermic storage demonstrated superior recovery of graft function and protection was correlated with increased inducible HSP70 protein expression.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, in addition to characterizing the pattern of HSP induction, we also wanted to investigate the effects of HP on kidney graft function in order to determine possible mechanisms of protection. Since recipient kidneys were not removed upon transplantation in most other studies [25], these studies allow no analysis of the effects of HP on renal functional parameters [14]. Therefore, we removed both native kidneys at transplantation so that functional parameters truly assessed solely graft function.…”
Section: Discussionmentioning
confidence: 99%